These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 35934599

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical characteristics, the diagnostic criteria and management recommendation of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) proposed by Japan Otological Society.
    Harabuchi Y, Kishibe K, Tateyama K, Morita Y, Yoshida N, Okada M, Kunimoto Y, Watanabe T, Inagaki A, Yoshida T, Imaizumi M, Nakamura T, Matsunobu T, Kobayashi S, Iino Y, Murakami S, Takahashi H, Tono T.
    Auris Nasus Larynx; 2021 Feb; 48(1):2-14. PubMed ID: 32768313
    [Abstract] [Full Text] [Related]

  • 4. Tympanic membrane findings of otitis media with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV).
    Morita Y, Kitazawa M, Yagi C, Nonomura Y, Takahashi K, Yamagishi T, Ohshima S, Izumi S, Horii A.
    Auris Nasus Larynx; 2020 Oct; 47(5):740-746. PubMed ID: 32173171
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The Quantification of Extracellular Trap Cell Death-Derived Products as Diagnostic Biomarkers for Otitis Media With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Eosinophilic Otitis Media.
    Morita S, Nakamaru Y, Fukuda A, Fujiwara K, Suzuki M, Hoshino K, Honma A, Homma A.
    Otol Neurotol; 2022 Mar 01; 43(3):e337-e343. PubMed ID: 34802016
    [Abstract] [Full Text] [Related]

  • 7. The association between ear involvement and clinical features and prognosis in ANCA-associated vasculitis.
    Hosokawa Y, Okada M, Suemori K, Hamaguchi N, Miyoshi KI, Takagi T, Teraoka M, Yamada H, Ishizaki J, Matsumoto T, Hato N.
    Auris Nasus Larynx; 2021 Oct 01; 48(5):885-889. PubMed ID: 33589280
    [Abstract] [Full Text] [Related]

  • 8. [Serological Study of Otitis Media with ANCA Associated Vasculitis (OMAAV)].
    Tateyama K, Kodama S, Nomi N, Suzuki M, Kishibe K, Harabuchi Y.
    Nihon Jibiinkoka Gakkai Kaiho; 2015 Sep 01; 118(9):1133-42. PubMed ID: 26615664
    [Abstract] [Full Text] [Related]

  • 9. Characteristics of and Prognosis for Facial Palsy in Patients With Otitis Media With ANCA-Associated Vasculitis (OMAAV).
    Fujiwara K, Morita S, Fukuda A, Yanagi H, Hoshino K, Nakamaru Y, Furuta Y, Homma A.
    Otol Neurotol; 2021 Dec 01; 42(10):e1577-e1582. PubMed ID: 34353982
    [Abstract] [Full Text] [Related]

  • 10. Otitis media with ANCA-associated vasculitis: A retrospective study of 30 patients.
    Tabei A, Sakairi T, Ohishi Y, Watanabe M, Nakasatomi M, Hamatani H, Ikeuchi H, Kaneko Y, Hiromura K.
    Mod Rheumatol; 2022 Aug 20; 32(5):923-929. PubMed ID: 34915561
    [Abstract] [Full Text] [Related]

  • 11. Anti-neutrophil cytoplasmic antibody-associated hypertrophic cranial pachymeningitis and otitis media: a review of literature.
    Peng A, Yang X, Wu W, Xiao Z, Xie D, Ge S.
    Eur Arch Otorhinolaryngol; 2018 Dec 20; 275(12):2915-2923. PubMed ID: 30328500
    [Abstract] [Full Text] [Related]

  • 12. Eosinophilic otitis media; state-of-the-art diagnosis and treatment.
    Iino Y.
    Auris Nasus Larynx; 2023 Aug 20; 50(4):479-489. PubMed ID: 36528403
    [Abstract] [Full Text] [Related]

  • 13. Fluorodeoxyglucose-positron emission tomography/computed tomography-positive ear lesions responsive to immunosuppressive therapy in a patient with otitis media with antineutrophil cytoplasmic antibody-associated vasculitis.
    Murao Y, Yoshida Y, Oka N, Yorishima A, Masuda S, Sugimoto T, Ono R, Hirokawa Y, Hirata S.
    Mod Rheumatol Case Rep; 2023 Jan 03; 7(1):134-137. PubMed ID: 35538047
    [Abstract] [Full Text] [Related]

  • 14. Vestibular Involvement in Patients With Otitis Media With Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
    Morita Y, Takahashi K, Izumi S, Kubota Y, Ohshima S, Horii A.
    Otol Neurotol; 2017 Jan 03; 38(1):97-101. PubMed ID: 27749752
    [Abstract] [Full Text] [Related]

  • 15. [Otitis media with antineutrophil cytoplasmic antibody-associated vasculitis].
    Zhang Y, Zhao H, Chen Z, Ren P, Hou W, Zhang Q, Wu Q, Jin Y, Yang J, Zhang Q.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Aug 03; 36(8):630-635. PubMed ID: 35959584
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The treatment outcomes of rituximab for intractable otitis media with ANCA-associated vasculitis.
    Okada M, Suemori K, Takagi D, Teraoka M, Yamada H, Ishizaki J, Matsumoto T, Hasegawa H, Hato N.
    Auris Nasus Larynx; 2019 Feb 03; 46(1):38-42. PubMed ID: 29885746
    [Abstract] [Full Text] [Related]

  • 18. Neutrophil Extracellular Trap Formation and Deoxyribonuclease I Activity in Patients with Otitis Media with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Morita S, Nakamaru Y, Fukuda A, Fujiwara K, Suzuki M, Hoshino K, Honma A, Nakazono A, Homma A.
    Int Arch Allergy Immunol; 2024 Feb 03; 185(8):810-819. PubMed ID: 38583424
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Labyrinthine calcification in ears with otitis media and antineutrophil cytoplasmic antibody-associated vasculitis (OMAAV): A report of two cases.
    Yoshida T, Kobayashi M, Sugimoto S, Naganawa S, Sone M.
    Auris Nasus Larynx; 2023 Apr 03; 50(2):299-304. PubMed ID: 35058072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.